Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists Francesco RodeghieroGiuseppe Carli Review Article 08 March 2017 Pages: 1421 - 1434
Non-seminomatous mediastinal germ cell tumor and acute megakaryoblastic leukemia Sarbajit MukherjeeSami IbrahimiMohamad Cherry Review Article 03 June 2017 Pages: 1435 - 1439
PD-1 signaling and inhibition in AML and MDS Faysal HarounSade A. SololaImad Tabbara Review Article 22 June 2017 Pages: 1441 - 1448
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy Oussama AblaRaul C. RibeiroMiguel A. Sanz Original Article 08 June 2017 Pages: 1449 - 1456
Evidence for a pre-existing telomere deficit in non-clonal hematopoietic stem cells in patients with acute myeloid leukemia MĂłnica S. Ventura FerreiraMartina CrysandtFabian Beier Original Article 03 July 2017 Pages: 1457 - 1461
Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase Mohamad JawharNicole NaumannGeorgia Metzgeroth Original Article 19 July 2017 Pages: 1463 - 1470
Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma Mamiko Sakata-YanagimotoRie Nakamoto-MatsubaraShigeru Chiba Original Article 20 June 2017 Pages: 1471 - 1475
Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal type Yu HuangJianliang YangYuankai Shi Original Article 11 July 2017 Pages: 1477 - 1483
High KIF2A expression predicts unfavorable prognosis in diffuse large B cell lymphoma Yaping ZhangXuefen YouWenyu Shi Original Article Open access 14 June 2017 Pages: 1485 - 1491
Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions Kathrin ThomayCaroline FedderGudrun Göhring Original Article 09 July 2017 Pages: 1493 - 1500
The influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin’s lymphomas Xiang ZhouKatharina LisenkoMathias Witzens-Harig Original Article 01 July 2017 Pages: 1501 - 1507
Interim 18F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine Jae-Cheol JoDok Hyun YoonCheolwon Suh Original Article 19 July 2017 Pages: 1509 - 1515
Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation Noriko DokiMasahiro SuyamaKazuteru Ohashi Original Article 21 July 2017 Pages: 1517 - 1523
Reduced BUCY 2 and G-CSF-primed bone marrow associates with low graft-versus-host-disease and transplant-related mortality in allogeneic HSCT Eucario Leon RodriguezMonica M. Rivera FrancoSandra I. Perez Alvarez Original Article 09 July 2017 Pages: 1525 - 1531
Clinical-associated characteristics and microbiological features of bloodstream nontyphoidal salmonella infection in adult patients receiving allogeneic hematopoietic stem cell transplantation Po-Shen KoYao-Chung LiuJyh-Pyng Gau Original Article 15 July 2017 Pages: 1533 - 1540
Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia Paolo RicchiAntonella MeloniAldo Filosa Original Article 14 July 2017 Pages: 1541 - 1546
Transcranial color Doppler in stroke-free adult patients with sickle cell disease G. GraziadeiF. M. CasoniM. D. Cappellini Original Article 20 July 2017 Pages: 1547 - 1555
Palliative home care for patients with advanced haematological malignancies—a multicenter survey F. KaiserL. v. RudloffB. Alt-Epping Original Article 21 June 2017 Pages: 1557 - 1562
Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination Neeraj SainiRajneesh NathJan Cerny Letter to the Editor 15 July 2017 Pages: 1563 - 1568
Low-dose nivolumab-induced responses in acute lymphoblastic leukaemia relapse after allogeneic haematopoietic stem cell transplantation Thomas S. Y. ChanJoycelyn P. Y. SimYok-Lam Kwong Letter to the editor 01 June 2017 Pages: 1569 - 1572
In Burkitt lymphoma patients who relapse after induction with a short-intensive chemoimmunotherapy protocol, aggressive salvage chemotherapy therapy is ineffective: a single-center retrospective study Martin CremerMark-Alexander SchwarzbichMathias Witzens-Harig Letter to the Editor 16 June 2017 Pages: 1573 - 1575
Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p) Marcelo Pitombeira de LacerdaNayara Ribeiro GuedesCelso Arrais Rodrigues Letter to the Editor 09 June 2017 Pages: 1577 - 1578
Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy Estelle BalducciVanessa NivaggioniMarie Loosveld Letter to the Editor 20 June 2017 Pages: 1579 - 1581
ABO genotype-phenotype discrepancy due to chimerism resolved by clonal separation Hyung-Seok YangJae Gyun ShinSeung Hwan Oh Letter to the Editor 20 June 2017 Pages: 1583 - 1585
Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients Hiroshi UreshinoKazuharu KamachiMasaharu Miyahara Letter to the Editor 27 June 2017 Pages: 1587 - 1588
Pregnancy in patients with thrombocytopenia and absent radii (TAR) syndrome Robert T. DiepMurat O. Arcasoy Letter to the Editor 20 July 2017 Pages: 1589 - 1590
Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice Pasquale NiscolaAndrea TendasPaolo de Fabritiis Letter to the Editor 12 July 2017 Pages: 1591 - 1593